New Advances in Fabrication of Graphene Glyconanomaterials for Application in Therapy and Diagnosis.
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
10 Mar 2020
10 Mar 2020
Historique:
received:
17
12
2019
accepted:
20
02
2020
entrez:
17
3
2020
pubmed:
17
3
2020
medline:
17
3
2020
Statut:
epublish
Résumé
Glycoderivatives are an important class of molecules with enormous relevance in numerous biological phenomena; therefore, they have a key role in the learning, understanding, and assessment of different diseases. Nanotechnology, and in particular the design of new nanomaterials, is one of the areas of greatest interest today. In this case, graphene nanomaterials represent very interesting platforms for studying glycosystems, glyconanomaterials that combine the biomolecular recognition and the characteristics of nanoscale objects in the development of early diagnosis systems, and efficient specific therapeutic modalities. In this mini-review, we discuss some results recently described in the literature on the conjugation of graphene materials and carbohydrates through the selective interaction of glycoenzymes in graphene to create new materials with biosensing applications, the development and application of sugar-graphene composites, and finally biosystems combining the properties of graphene with metallic nanoparticles and sugars for the creation of excellent glyconanomaterials as novel systems for the therapy or diagnosis of important diseases such as cancer or diabetes.
Identifiants
pubmed: 32175483
doi: 10.1021/acsomega.9b04332
pmc: PMC7066556
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
4362-4369Informations de copyright
Copyright © 2020 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Mater Sci Eng C Mater Biol Appl. 2019 Dec;105:110075
pubmed: 31546385
Mater Sci Eng C Mater Biol Appl. 2020 Feb;107:110329
pubmed: 31761178
Nanotechnology. 2018 Nov 23;29(47):475604
pubmed: 30191889
Mater Sci Eng C Mater Biol Appl. 2020 Feb;107:110273
pubmed: 31761219
Polymers (Basel). 2019 Jan 14;11(1):
pubmed: 30960117
Methods Enzymol. 2018;609:293-333
pubmed: 30244795
Chem Commun (Camb). 2019 Jun 13;55(49):6964-6996
pubmed: 31140997
Anal Chim Acta. 2019 Oct 31;1078:42-52
pubmed: 31358227
Biosens Bioelectron. 2019 Jun 15;135:1-7
pubmed: 30981027
Diabetes Care. 2017 Jan;40(Suppl 1):S11-S24
pubmed: 27979889
Chem Soc Rev. 2019 Jan 2;48(1):38-71
pubmed: 30387803
Biosens Bioelectron. 2019 Mar 1;128:23-31
pubmed: 30616214
J Colloid Interface Sci. 2018 Apr 15;516:332-341
pubmed: 29408121
J Am Chem Soc. 2018 Apr 25;140(16):5421-5426
pubmed: 29624385
Sci Adv. 2019 Jun 07;5(6):eaaw3192
pubmed: 31187061
Nat Protoc. 2012 Oct;7(10):1783-96
pubmed: 22955694
Carbohydr Polym. 2018 Nov 15;200:93-99
pubmed: 30177213
Nanomaterials (Basel). 2019 Sep 19;9(9):
pubmed: 31546926
Biosensors (Basel). 2019 Jan 28;9(1):
pubmed: 30696069
ACS Omega. 2019 Sep 17;4(14):15824-15828
pubmed: 31592149
Biosens Bioelectron. 2016 Feb 15;76:113-30
pubmed: 26212205
Nanomaterials (Basel). 2018 Oct 11;8(10):
pubmed: 30314340
Biosens Bioelectron. 2019 Jan 1;123:85-100
pubmed: 29903690
Nat Mater. 2019 Oct;18(10):1133-1143
pubmed: 31133729